EP3749955A1 - Verfahren zur quantifizierung von gesamtgluten aus getreide in lebensmittelproben - Google Patents
Verfahren zur quantifizierung von gesamtgluten aus getreide in lebensmittelprobenInfo
- Publication number
- EP3749955A1 EP3749955A1 EP19701280.0A EP19701280A EP3749955A1 EP 3749955 A1 EP3749955 A1 EP 3749955A1 EP 19701280 A EP19701280 A EP 19701280A EP 3749955 A1 EP3749955 A1 EP 3749955A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- gluten
- wheat
- total
- antibodies
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010068370 Glutens Proteins 0.000 title claims abstract description 149
- 235000021312 gluten Nutrition 0.000 title claims abstract description 87
- 238000000034 method Methods 0.000 title claims abstract description 42
- 235000013305 food Nutrition 0.000 title claims abstract description 36
- 238000011002 quantification Methods 0.000 title claims abstract description 14
- 238000001514 detection method Methods 0.000 claims abstract description 39
- 108060006613 prolamin Proteins 0.000 claims abstract description 35
- XXRYFVCIMARHRS-UHFFFAOYSA-N propan-2-yl n-dimethoxyphosphorylcarbamate Chemical compound COP(=O)(OC)NC(=O)OC(C)C XXRYFVCIMARHRS-UHFFFAOYSA-N 0.000 claims abstract description 25
- 238000012360 testing method Methods 0.000 claims abstract description 15
- 235000021307 Triticum Nutrition 0.000 claims description 60
- 235000013312 flour Nutrition 0.000 claims description 34
- 239000000523 sample Substances 0.000 claims description 33
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 32
- 241000209056 Secale Species 0.000 claims description 31
- 235000007238 Secale cereale Nutrition 0.000 claims description 31
- 238000000605 extraction Methods 0.000 claims description 27
- 241000209219 Hordeum Species 0.000 claims description 26
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 24
- 238000002965 ELISA Methods 0.000 claims description 23
- 235000018102 proteins Nutrition 0.000 claims description 23
- 102000004169 proteins and genes Human genes 0.000 claims description 23
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- 238000003118 sandwich ELISA Methods 0.000 claims description 19
- 239000000284 extract Substances 0.000 claims description 17
- 235000013339 cereals Nutrition 0.000 claims description 15
- 241000209140 Triticum Species 0.000 claims description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims description 14
- 108010061711 Gliadin Proteins 0.000 claims description 13
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 10
- 108010050792 glutenin Proteins 0.000 claims description 8
- 239000012089 stop solution Substances 0.000 claims description 7
- 238000003556 assay Methods 0.000 claims description 6
- 230000009870 specific binding Effects 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- 230000027455 binding Effects 0.000 claims description 4
- 238000009739 binding Methods 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 4
- 238000011534 incubation Methods 0.000 claims description 4
- 239000011534 wash buffer Substances 0.000 claims description 4
- HZWWPUTXBJEENE-UHFFFAOYSA-N 5-amino-2-[[1-[5-amino-2-[[1-[2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid Chemical compound C1CCC(C(=O)NC(CCC(N)=O)C(=O)N2C(CCC2)C(=O)NC(CCC(N)=O)C(O)=O)N1C(=O)C(N)CC1=CC=C(O)C=C1 HZWWPUTXBJEENE-UHFFFAOYSA-N 0.000 claims description 3
- 238000002493 microarray Methods 0.000 claims description 3
- 239000012898 sample dilution Substances 0.000 claims description 3
- 229920000344 molecularly imprinted polymer Polymers 0.000 claims 2
- 108091023037 Aptamer Proteins 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010003723 Single-Domain Antibodies Proteins 0.000 claims 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims 1
- 108010092262 T-Cell Antigen Receptors Proteins 0.000 claims 1
- 239000008240 homogeneous mixture Substances 0.000 claims 1
- 108020003175 receptors Proteins 0.000 claims 1
- 229940127121 immunoconjugate Drugs 0.000 abstract description 5
- 238000005259 measurement Methods 0.000 abstract description 4
- 244000098338 Triticum aestivum Species 0.000 description 54
- 239000000243 solution Substances 0.000 description 22
- 230000009257 reactivity Effects 0.000 description 16
- 238000005406 washing Methods 0.000 description 14
- 235000019624 protein content Nutrition 0.000 description 11
- 239000000427 antigen Substances 0.000 description 10
- 102000036639 antigens Human genes 0.000 description 10
- 108091007433 antigens Proteins 0.000 description 10
- 230000002860 competitive effect Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 239000012528 membrane Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 208000015943 Coeliac disease Diseases 0.000 description 5
- 238000012286 ELISA Assay Methods 0.000 description 5
- 230000009260 cross reactivity Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 235000007319 Avena orientalis Nutrition 0.000 description 3
- 244000075850 Avena orientalis Species 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- PGLIUCLTXOYQMV-UHFFFAOYSA-N Cetirizine hydrochloride Chemical compound Cl.Cl.C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 PGLIUCLTXOYQMV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 240000000359 Triticum dicoccon Species 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 230000003196 chaotropic effect Effects 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- 238000010079 rubber tapping Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 108010032595 Antibody Binding Sites Proteins 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 235000001468 Triticum dicoccon Nutrition 0.000 description 1
- 240000000581 Triticum monococcum Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 235000011868 grain product Nutrition 0.000 description 1
- 229960004198 guanidine Drugs 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 235000020790 strict gluten-free diet Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000003108 two site enzyme immunoassay Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56961—Plant cells or fungi
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/02—Food
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
Definitions
- the invention relates to a method for quantifying total gluten from cereals in food samples. Areas of application are above all the food industry, service laboratories and state control laboratories or biotechnology.
- Celiac disease is a partially autoimmune disease that causes damage to the small intestine resulting in diarrhea, vomiting, nutritional deficiencies and weight loss. Since the disease is not curable, only the strict gluten-free diet remains for the patient. Celiac patients who follow such a diet live largely symptom-free. The patients are thus dependent on food containing no or very little gluten.
- Codex Alimentarius describes the requirement for foods that are considered “gluten-free”.
- the current standards define foods as "gluten-free” if they are less than 20 mg gluten per kg of food (Codex Standard 118 - 1979).
- Other countries and regions such as For example, the EU, US and Canada have adopted their legal regulations to this Codex limit. Food manufacturers wishing to provide celiac disease patients with "gluten-free" products need to review and comply with this limit on their products.
- Gluten is a heterogeneous protein mixture of alcohol-soluble prolamins and alcohol-insoluble glutelins.
- Gluten proteins are found in all Triticum species (eg wheat, spelled, emmer, einkorn), rye and barley, as well as in their crosses and are differentiated depending on the type of cereal.
- prolamins are called gliadins and glutelinins are subdivided into low molecular weight glutenin subunit (LMW) proteins and high molecular weight glutenin subunit (HMW) proteins.
- LMW low molecular weight glutenin subunit
- HMW high molecular weight glutenin subunit
- Gluten proteins is currently the enzyme-linked immunosorbent assay (ELISA).
- Extraction solutions containing the reducing substances (eg ⁇ -mercaptoethanol, sulfite, thiosulfite), denaturing substances (eg guanidine hydrochloride, urea) and / or detergents (eg Tween , Triton-X100, sodium dodecyl sulfate).
- reducing substances eg ⁇ -mercaptoethanol, sulfite, thiosulfite
- denaturing substances eg guanidine hydrochloride, urea
- detergents eg Tween , Triton-X100, sodium dodecyl sulfate.
- cocktail extraction solution EP 1 424 345 A1, license from R-Biopharm AG. All extraction solutions are used together with ethanol or isopropanol.
- the color reaction is carried out by adding a substrate / chromogen solution.
- the reaction is stopped by sulfuric acid and the optical density (OD) measured by photometer.
- the quantification is carried out using calibrators of known gliadin content. From the gliadin content thus obtained, the total gluten content is calculated by multiplication by the factor 2. This multiplication is prescribed according to Codex-Alimentarius (CODEX-STAN 118 - 1979). However, it is becoming increasingly clear that a general factor 2 leads in many cases to a miscalculation (Wieser and Köhler, 2009). So z. B. wheat flour both in the total protein content as well as in the composition of gluten proteins significantly different (Hajas et al., 2017). If only the prolamine content is determined, this may lead to falsified results in the calculation of the total gluten content in the case of different composition of the individual gluten protein fractions.
- gluten fractions can be selectively ablated or enriched so that only a partial determination of the gluten fractions can lead to significant incorrect determinations (Wieser and Köhler 2009).
- EP 1 1779 115 B1 discloses antibodies against T-cell recognition sequences in gliadin (prolamine in wheat) or in LMW and HMW (gluteline in wheat) and their use in ELISA assays.
- gliadin prolamine in wheat
- LMW and HMW gluteline in wheat
- ELISA assays there is no common detection, but only either detection of prolamin or LMW or HMW.
- the Separate detection is also highlighted as particularly beneficial. There is therefore no adequate quantification of total gluten from wheat and / or rye and / or barley in an ELISA.
- Skerritt et al. (1989) published several antibody combinations that can partially detect prolamins, LMW and HMW.
- the aim of the invention is to determine the total gluten content in foods quickly and cheaply with only one measurement, whereby each gluten protein fraction is to be quantified according to its mass fraction.
- the object of the present invention is derived to develop a method with which, based on the detection of prolamins and glutelins, all potentially celiac-relevant gluten protein fractions in food samples are quantified according to their masses as a sum, wherein the quantification by combination multiple antibodies in a well and in a conjugate.
- the method should be used to determine the total gluten content from wheat samples.
- Related gluten fractions in other Triticum species, rye and barley should also be quantifiable by the method.
- the present method is based on the common use of specific prolamin and glutelin antibodies as a combination conjugate according to the invention for the detection of total gluten.
- a combination of specific binding reagents against prolamins and glutelin is used in a single analytical run, these specific binding reagents being mixed in one unit.
- a dilution of the individual antibody conjugates takes place in such a way that the contribution of the individual antibodies to the total signal strength corresponds to the fraction of the gluten fraction which they each detect.
- the total gluten determination is preceded by the extraction of gluten proteins from the food.
- an extraction method is used, which under reductive conditions with the addition of chaotropic salts in the presence of aliphatic short-chain alcohols, gluten proteins from the food matrix dissolves.
- the extract obtained is then used for the total gluten determination in an antibody-based detection method z. B. in an ELISA (sandwich or competitive or direct format) or lateral flow format or flow through used.
- ELISA sandwich or competitive or direct format
- the antigen is specifically bound by two antibodies.
- the first antibody (capture antibody) is bound to the solid phase of the wells (wells) of a microtiter plate.
- the sample with the antigen to be detected is then added to the wells and incubated. During this time, the antibody bound to the plate binds the antigen present in the sample. After the incubation phase, the plate is washed. The unbound components of the sample are thereby removed. This leaves only the antigen bound to the capture antibody.
- a second antibody for detection (detection antibody) is added, which binds to a site in the antigen other than the capture antibody and at the end of which a reporter enzyme is bound.
- This second antibody thus also binds to the antigen, only at a different position, and results in an antibody-antigen-antibody complex, which is also referred to as a sandwich complex.
- a substrate suitable for the reporter enzyme also called "chromogen”
- chromogen is added, which is converted by the reporter enzyme to a reaction product and thus enables its detection by color change.
- reporter enzyme instead of the reporter enzyme would be direct fluorescence or chemoluminescence labeling of the detector antibody.
- a series of known antigen concentrations (standard series) is usually carried along in order to obtain a calibration curve for the measured signal.
- standard series a series of known antigen concentrations
- a microtiter plate is coated with a combination of antibodies to wheat prololamine, LMW and HMW proteins, each cavity being coated with the mixture of antibodies. Subsequently, the extracted sample is added. The extracted gluten proteins bind specifically to these capture antibodies.
- the combined addition according to the invention of detection antibodies to wheat prololamine, LMW and HMW proteins takes place, the conjugated antibodies being present in a solution (combination conjugate).
- detection antibodies are conjugated so that their binding becomes quantifiable. This can be z. B. be made by conjugation with a dye-forming reporter enzyme.
- the conjugated detection antibodies used against prolamins and glutelin in the combination conjugate according to the invention are mixed in such a way that all gluten fractions are measured at the same mass fraction with comparable signal strength.
- the quantification is done by comparing the total signal strength of a sample with the signal strengths of gluten calibrators of known content.
- As an extract of wheat flour can be used.
- the total gluten determination is preceded by the extraction of the gluten proteins from the sample to be investigated with the addition of chaotropic salts in the presence of aliphatic short-chain alcohols.
- a cocktail extraction solution [0.76 g / L NaCl, 0.244 g / L KCl, 1.42 g / L Na 2 HPO 4 * 2H 2 O, 0.272 g / LH 2 K0 4 P, 191 g / L guanidine-HCl, 18.2 ml / L ⁇ -mercaptoethanol] (EP 1 424 345 A1).
- - Thoroughly homogenise a sufficiently large amount of the sample (at least 5 g or 5 ml) (carefully crush, finely grind and mix well or mix the solution well).
- Tannin and polyphenol-containing food samples (eg chocolate, coffee, cocoa, chestnut flour, buckwheat, millet and spices): Weigh out 0.25 g of the homogenised sample, 0.25 g skimmed milk powder and 2.5 ml cocktail extraction solution (EP 1 424 345 A1), close the container and mix well
- the gluten distribution can be very uneven, in addition, these samples are difficult to homogenize. For this reason, homogenize 200 g of sample, then sample at least four times: Weigh out 1 g of the homogenized sample and add 10 ml of cocktail extraction solution, close the tube and mix well.
- the sample 1 25 (40 ml + 960 ml) with buffer, z. B. pH neutral phosphate buffer further diluted: the final dilution factor is 1000.
- the samples thus obtained are then used for total gluten determination, preferably in a sandwich ELISA.
- the following describes by way of example the performance of a sandwich ELISA for the determination of total gluten of wheat-containing samples.
- An essential advantage of the invention is that the total gluten content is determined with a single measurement step in a single cavity.
- LMW and HMW glutenin wheat gluteline
- Bindings are saturated by block and stabilization solutions known from the literature, and then the extracted sample or the standard (calibrator) is preferably added as double samples into the individual wells.
- the gluten proteins from a wheat flour are isolated by means of modified Osborne fractionation (Schalk et al., 2017). To improve the durability, the gluten isolate thus obtained is brought to dryness and stored. To prepare the calibrators, this isolate is weighed in, dissolved by means of cocktail extraction solution (EP 1 424 345 A1) R-Biopharm (product number R7006) and diluted to the desired concentrations in a pH-neutral phosphate buffer.
- the detection antibodies against gliadin wheat prolamine
- LMW and HMW glutenin wheat gluteline
- a reporter enzyme conjugated with a reporter enzyme.
- This mixture of detection antibodies which bind to gluten proteins at different sites than the capture antibodies is referred to below as a combination conjugate.
- the microtiter plate with a gluten extract, z. B. coated from a wheat flour In a competitive ELISA with antigen coating, the microtiter plate with a gluten extract, z. B. coated from a wheat flour.
- the calibrator is identical to the one used in the sandwich ELISA procedure.
- the preparation and adjustment of the individual conjugates and the combination conjugate are carried out as in the sandwich ELISA method, however, the OD decreases in a competitive ELISA with increasing gluten concentrations.
- the sample extraction is identical to that in the sandwich ELISA method.
- the color reagent is added.
- the reaction is stopped by adding the stop solution.
- a competitive ELISA with antibody coating the microtiter plate is coated with a solution of prolamine, LMW and HMW antibodies so that all antibodies are bound in each well.
- the calibrator is identical to the one used in the sandwich ELISA procedure.
- conjugates the single protein fractions Prolamine, LMW and HMW are coupled to horseradish peroxidase.
- the individual conjugates and the combination conjugate are adjusted analogously to the sandwich ELISA method, but the OD decreases in a competitive ELISA with increasing gluten concentrations.
- the sample extraction is identical to that in the sandwich ELISA method.
- calibrators or samples are added to the wells and incubated in the first step. After an optional washing step, the combination conjugate is pipetted into the wells and incubated. After a (re) washing step, the color reagent is added and incubated. In the last step, the reaction is stopped by adding the stop solution.
- the horseradish peroxidase is not stable to the cocktail extraction solution in the samples. Therefore, the prolamine, LMW and HMW fractions must be conjugated differently in this case, e.g. B. to biotin.
- the detection of streptavidin coupled via horseradish peroxidase takes place.
- the color reagent is added and incubated. In the last step, the reaction is stopped by adding the stop solution.
- a direct ELISA an uncoated microtiter plate is used.
- the calibrator is identical to the one used in the sandwich ELISA procedure.
- the preparation and adjustment of the individual conjugates and the combination conjugate are carried out as in the sandwich ELISA method.
- the sample extraction is identical to that in the sandwich ELISA method.
- the uncoated microtiter plate is incubated with the calibrators or the samples. After a washing step, the combination conjugate is next added and incubated. After a new washing step, the color reagent is added and incubated. In the last step, the reaction is stopped by adding the stop solution.
- Lateral flow formats can follow the sandwich or competitive principle.
- the surface of a strip-shaped membrane is coated with a solution of a mixture of prolamine, LMW and HMW antibodies in the form of a narrow line across the direction of flow (see Fig. 1).
- the gluten-containing sample solution is transported via an absorbent material into the area of the lateral flow, in which a mixture of labeled prolamin, LMW and HMW antibodies are in dried form.
- the conjugated detection antibodies used against prolamins and glutelin in the combination conjugate according to the invention are mixed in such a way that all gluten fractions are measured at the same mass fraction with comparable signal strength.
- the labeling of the antibodies follows the methods known to the experts (eg in the form of colloidal gold, colored, fluorescent or phosphorescent nanoparticles).
- the gluten proteins react with the respective labeled specific antibody and are transported by capillary forces further to the area of the membrane which has been coated with membrane-bound prolamin, LMW and HMW antibodies as described above.
- the gluten-antibody complexes react with the membrane-bound antibodies to form a sandwich, which becomes visible through the formation of a colored band.
- the signal strength of the band corresponds to the amount of gluten in the sample.
- Another band serves as a control band and indicates the general functionality of the lateral flow.
- the competitive lateral-flow format follows the principles of the competitive ELISA described above, wherein the gluten from the sample is first reacted with labeled specific antibodies and then transported along the membrane by capillary forces until it encounters a sample band of immobilized gluten. A reduction in the intensity of the sample band indicates the presence of gluten.
- the labeled antibodies used against prolamins and glutelin in the combination conjugate according to the invention are mixed in such a way that all gluten fractions are measured at the same mass fraction with comparable signal strength.
- marked gluten is located on the starting line of the lateral flow, which together with the non-labeled gluten from the Sample transported by capillary forces onto the test band with immobilized specific unlabeled antibodies.
- a competition reaction takes place around the antibody binding sites.
- the mixed antibodies used against prolamins and glutelin in the test band and the labeled, mixed gluten proteins on the starting line of the lateral flow are mixed according to the invention such that all gluten fractions are measured with the same mass fraction with comparable signal strength. As a result, the band becomes more intense when there is less gluten in the sample.
- flow-through formats follow the functional principles of lateral-flow formats already described, differing only in the fact that the mass transfer does not take place along a membrane but through it. Adjustments to the described lateral flow rates can be found in the relevant literature or are known to the expert.
- Microarray and microfluidic formats follow the principles of ELISA and lateral flow formats already described. Further specific details can be found in the relevant literature or are known to the expert.
- a gliadin antibody against the epitope QQPFP is used as a prolamine detection antibody and as glutelin
- Detection antibody used an antibody against the LMW fraction extracted from wheat flour and an antibody against HMW with the epitope recognition sequence GYYPTS.
- the various detection antibodies are coupled separately to horseradish peroxidase using commercial conjugation reagents (eg, Pierce TM Conjugate Purification Kit catalog number 44920).
- the antibody conjugates thus obtained are then mixed according to the invention in such a way that all gluten fractions are measured at the same mass fraction with comparable signal strength.
- the individual conjugates are mixed in a small batch and the reactivity of the combination conjugate is checked as described above and, if appropriate, the dilution factors of the individual conjugates are further adjusted. Only after a successful approach in the small-scale approach, the individual conjugates are combined as a whole.
- Table 1 shows the example of such a pre-test.
- the specific antibody conjugates are first tested individually with the above-mentioned coated microtiter plate.
- Wheat whole gluten extract is diluted to three different concentrations, each containing the same amount of either prolamine, LMW or HMW proteins.
- a total gluten extract with the concentration 15.5 ng / ml total gluten protein contains 10 ng / ml gliadin.
- a total gluten extract containing 44.5 ng / ml total gluten protein contains 10 ng / ml LMW proteins
- a total glutinous extract containing 80 ng / ml contains 10 ng / ml HMW proteins (see Table 1).
- Table 1 Selection of total gluten concentrations at which the concentration of the individual fractions has the same value. All data in ng / ml.
- the gliadin, LMW and HMW-specific antibody conjugates are now adjusted so that the gliadin antibody with the 15.5 ng / ml total glutinous extract has the same signal strength (in the example in Table 2: 2.0) as the LMW Antibody with the 44.5 ng / ml total gluteal extract and the HMW antibody with the 80 ng / ml total glutinous extract (Table 2).
- Table 2 Example of pre-testing of single conjugate dilutions.
- the combination conjugate is checked with calibration series of the individual fractions (wheat prolamine, LMW and HMW proteins) (see Figure 2 and Figure 3). Possibly. there is a further adaptation of the composition of the combination conjugate.
- the individual fractions are obtained by extraction of all proteins from a wheat flour and subsequent separation by HPLC (Schalk et al., 2017). To improve the shelf life, the resulting protein isolates are brought to dryness and stored. To prepare the stock solutions, the fractions are weighed, dissolved by means of cocktail extraction solution (EP 1 424 345 A1) and diluted in a pH neutral phosphate buffer to the desired concentrations.
- Wheat flours can be significantly different both in the total protein content and in the composition of the gluten proteins (Hajas et al., 2017). Due to the setting of the individual conjugates, differences in the composition of the gluten proteins should have no influence on the measurement, since the same amount of single fraction protein leads to a comparable signal, no matter which wheat protein fraction it is (see Figure 2). The fact that all celiac-relevant gluten protein fractions are determined, in contrast to conventional test methods (see prior art), the total gluten content is not falsified with different gluten protein composition.
- LMW proteins do not have any homologous proteins in rye and barley, so that cross-reactivity can not be expected here.
- the barley glutelinels have little homology to wheat and rye proteins, so detection of this fraction with antibodies to prolamins, HMW and LMW proteins is not likely.
- barley flours show a greater range of variation ( Figures 8 and 9). This is probably due to the fact that the barley fractions are detected differently in contrast to the wheat and rye fractions. As was to be expected, barley gluten infraction is not significantly detected by any of the antibodies used, while prolamins are detected very well. Accordingly, slight shifts in the protein fractions in the various flours would lead to significant differences. In a general over-or under-determination of cereals compared to a Wheat Calibrator can be used for more accurate gluten content determination, a calibrator with material from the corresponding other crops.
- the claimed method makes possible the simultaneous determination of prolamin and glutelin proteins by the use of the combination conjugate according to the invention and thus for the first time allows a quantification of the actual total gluten content.
- This method of co-determination of prolamine and glutelins is much more accurate than previously known methods, in which only the prolamine content is determined, from which in turn the total gluten content is calculated.
- the celiac disease-relevant glutelin have not been determined, which could lead to wrong results in the past. The claimed method closes this gap.
- the method of the invention is not only suitable for determining the total gluten content of wheat-containing food samples, but also for the determination of the total gluten content of other Triticum species, and / or rye and / or barley-containing food samples.
- FIG. 1 Schematic operation of a lateral-flow assay in
- Fig. 3 Testing the reactivity of the combination conjugate against the different wheat flour fractions. Measured concentrations for various wheat flour fractions at a target value of 20 ng / ml
- Fig. 5 Testing the reactivity of the combination conjugate against various commercial wheat flours and pure wheat varieties whose gluten protein content was determined by FIPLC.
- Fig. 7 Testing the reactivity of the combination conjugate against various commercial rye flours and pure rye varieties whose gluten protein content was determined by HPLC and purified rye fractions. Measured concentrations at a target value of 20 ng / ml Fig. 8 Testing of the reactivity of the combination conjugate against various commercial barley flours and pure barley varieties, whose gluten protein content was determined in each case by HPLC, and purified barley fractions
- Tye-Din J., Stewart, J., Dromey, J., Beissbarth, T., van Heel, D., Tatham, A., Henderson, K., Mannering, S., Gianfrani, C., Jewell , D., Hill, A., McCluskey, J., Rossjohn, J. and Anderson, R. (2010) Comprehensive, Quantitative Mapping of T Cell Epitopes in Gluten in Celiac Disease. Be. Trans. Med. 2: 41 ra51.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18000114.1A EP3524983A1 (de) | 2018-02-08 | 2018-02-08 | Verfahren zur quantifizierung von gesamtgluten aus getreide in lebensmittelproben |
| PCT/EP2019/025002 WO2019154559A1 (de) | 2018-02-08 | 2019-01-03 | Verfahren zur quantifizierung von gesamtgluten aus getreide in lebensmittelproben |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP3749955A1 true EP3749955A1 (de) | 2020-12-16 |
Family
ID=61192634
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP18000114.1A Withdrawn EP3524983A1 (de) | 2018-02-08 | 2018-02-08 | Verfahren zur quantifizierung von gesamtgluten aus getreide in lebensmittelproben |
| EP19701280.0A Pending EP3749955A1 (de) | 2018-02-08 | 2019-01-03 | Verfahren zur quantifizierung von gesamtgluten aus getreide in lebensmittelproben |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP18000114.1A Withdrawn EP3524983A1 (de) | 2018-02-08 | 2018-02-08 | Verfahren zur quantifizierung von gesamtgluten aus getreide in lebensmittelproben |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20200400638A1 (de) |
| EP (2) | EP3524983A1 (de) |
| AU (1) | AU2019218334B2 (de) |
| WO (1) | WO2019154559A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250369965A1 (en) * | 2024-05-28 | 2025-12-04 | LEO Verification Systems, Inc. | Formulation, a kit, and method for food allergen detection |
| CN119595679B (zh) * | 2024-12-16 | 2025-10-17 | 四川大学 | 一种植鞣皮革文物的鉴定方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4208479A (en) * | 1977-07-14 | 1980-06-17 | Syva Company | Label modified immunoassays |
| US4208476A (en) * | 1978-06-19 | 1980-06-17 | The Quaker Oats Company | Steam injection extrusion apparatus, process, and the resultant product |
| US6183972B1 (en) * | 1998-07-27 | 2001-02-06 | Bayer Corporation | Method for the determination of analyte concentration in a lateral flow sandwich immunoassay exhibiting high-dose hook effect |
| US6767710B2 (en) * | 2001-03-30 | 2004-07-27 | Praxsys Biosystems, Llc | Prewetting stop flow test strip |
| ES2182698B1 (es) | 2001-05-14 | 2004-09-16 | Consejo Superior De Investigaciones Cientificas | Procedimiento para la extraccion cuantitativa de gluten en alimentos procesados o no procesados por calor, y composicion solubilizante de proteinas de gluten o un kit comercial que la contenga necesarios para su puesta en practica. |
| DE10154458B4 (de) * | 2001-11-08 | 2009-10-29 | Universität Leipzig | Peptide zur Analyse von Gluten in Lebensmitteln und anderen Substanzgemischen und deren Verwendung |
| WO2003062824A1 (en) * | 2002-01-23 | 2003-07-31 | Boditech Inc. | Lateral flow quantitative assay method and strip and laser-induced fluoerescence detection device therefor |
| CN102430111B (zh) * | 2004-04-28 | 2018-03-02 | 英国技术集团国际有限公司 | 与腹部疾病有关的表位 |
| EP1612558A1 (de) | 2004-06-30 | 2006-01-04 | Academisch Ziekenhuis Leiden | Verfahren zum Nachweis von Gluten |
| WO2011008682A1 (en) * | 2009-07-17 | 2011-01-20 | Siemens Healthcare Diagnostics Inc | Urinary trypsin inhibitors as diagnostic aid for interstitial cystitis |
| US10466238B2 (en) * | 2010-12-28 | 2019-11-05 | Universidad De Sevilla | Determination of levels of immunogenic gluten peptides in human samples |
| US10254279B2 (en) * | 2013-03-29 | 2019-04-09 | Nima Labs, Inc. | System and method for detection of target substances |
| CN107430108A (zh) * | 2015-03-09 | 2017-12-01 | 第6感传感器实验室公司 | 用于检测消费品中的过敏原的方法和系统 |
-
2018
- 2018-02-08 EP EP18000114.1A patent/EP3524983A1/de not_active Withdrawn
-
2019
- 2019-01-03 US US16/968,473 patent/US20200400638A1/en active Pending
- 2019-01-03 WO PCT/EP2019/025002 patent/WO2019154559A1/de not_active Ceased
- 2019-01-03 AU AU2019218334A patent/AU2019218334B2/en active Active
- 2019-01-03 EP EP19701280.0A patent/EP3749955A1/de active Pending
Non-Patent Citations (1)
| Title |
|---|
| ELLIS H J ET AL: "Measurement of gluten using a monoclonal antibody to a coeliac toxic peptide of A gliadin", GUT MICROBIOTA, vol. 43, no. 2, 1 August 1998 (1998-08-01), UK, pages 190 - 195, XP093259630, ISSN: 0017-5749, DOI: 10.1136/gut.43.2.190 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20200400638A1 (en) | 2020-12-24 |
| AU2019218334B2 (en) | 2025-07-10 |
| EP3524983A1 (de) | 2019-08-14 |
| WO2019154559A1 (de) | 2019-08-15 |
| AU2019218334A1 (en) | 2020-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Scherf et al. | Recent developments in analytical methods for tracing gluten | |
| EP0407904B1 (de) | Verfahren zur Bestimmung eines Analyten | |
| JP7253306B2 (ja) | 免疫比濁法によるカルシウム結合タンパク質s100ファミリーメンバーの測定方法 | |
| US11035764B2 (en) | Extraction of mycotoxins | |
| WO2008141351A1 (de) | Verfahren zur quantitativen bestimmung von analyten mit einem testelement sowie testsystem und verwendung desselben | |
| EP0356964B1 (de) | Verfahren zur Bestimmung einer spezifisch bindefähigen Substanz | |
| DE60202008T2 (de) | Verfahren zum Auffinden von Reagenzien und Festphasenkomponenten in spezifischen Bindungsassays, frei von fortgeschrittenen Glykosylierungsendprodukten | |
| Maddens et al. | Validation of immunoassays for the candidate renal markers C-reactive protein, immunoglobulin G, thromboxane B2 and retinol binding protein in canine urine | |
| WO2019154559A1 (de) | Verfahren zur quantifizierung von gesamtgluten aus getreide in lebensmittelproben | |
| DE3822750A1 (de) | Verfahren zur bestimmung einer spezifisch bindefaehigen substanz | |
| Pospiech et al. | Immunohistochemical detection of soya protein–optimisation and verification of the method | |
| DE69808895T2 (de) | Leistungssteigerung von bindungsassays mit verwendung mehr als einer markierungsmittel | |
| Valdés et al. | Development of MS-based methods for identification and quantification of proteins altered during early pregnancy in dogs | |
| EP2986985B1 (de) | Automatisierbares verfahren zur identifizierung, quantifizierung und diskriminierung von spezifischen signalen gegenüber unspezifischen signalen in nachweisverfahren mittels detektor | |
| DE102011109063B3 (de) | Verfahren zum Nachweis von Biomolekülen | |
| DE60019988T2 (de) | Verfahren zur Bestimmung von Rezeptorbindungseigenschaften und Reagenz zum Assay | |
| Brett et al. | Identification of hidden allergens within foods | |
| Singkong et al. | Zearalenone contamination in corn for human consumption in Kamphaengphet, Thailand | |
| EP1135689B1 (de) | Stabilisierung von cytokeratin enthaltenden kalibratoren | |
| DE10154458B4 (de) | Peptide zur Analyse von Gluten in Lebensmitteln und anderen Substanzgemischen und deren Verwendung | |
| Jin et al. | A novel colloidal gold labeled antigen for the detection of Deoxynivalenol using an immunochromatographic assay method | |
| Khapanya et al. | Development of one-step immunochromatographic strip for the detection of total aflatoxin in corn sample based on monoclonal antibody clone 4 G6. | |
| DE4006054A1 (de) | Verfahren zur immunologischen bestimmung von liganden | |
| US20220236151A1 (en) | Extraction of mycotoxins | |
| Ward et al. | Food immunoassay |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20200903 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230526 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20240118 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20240909 |
|
| GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| INTC | Intention to grant announced (deleted) |